Skip to main content

Advertisement

Log in

Association of a variant in the tumor necrosis factor alpha gene with risk of cervical cancer

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Tumor necrosis factor alpha (TNF-α) is a pro-inflammatory cytokine involved in the regulation of the immune system and potentially the progression of cervical neoplastic lesions. In this study, we aimed to explore the possible relationship between polymorphisms of the TNF-α gene and susceptibility to cervical cancer. The relationship between a single nucleotide polymorphism (SNP) in the TNF-α gene (rs1800629) and the risk of cervical cancer was evaluated in a total of 445 subjects with (n = 153), or without (n = 292) cancer. Genotyping was performed using a Taq-Man based real time PCR method. Logistic regression analysis showed that individuals with AG/AA genotypes had an increased risk of cervical cancer compared to those with a GG genotype (OR 3.79, 95% CI 2.4–5.7, < 0.001). Our findings demonstrated that a genetic variant in the TNF-α gene (rs1800629) was associated with increased level and risk of developing cervical cancer, suggesting its potential use as a genetic risk factor for cervical neoplasia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Lee S, Margolin K (2011) Cytokines in cancer immunotherapy. Cancers 3(4):3856–3893

    Article  CAS  Google Scholar 

  2. Mantovani A, Dejana E (1989) Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 10(11):370–375

    Article  CAS  Google Scholar 

  3. Newton K, Dixit VM (2012) Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol 4(3):a006049

    Article  Google Scholar 

  4. Balkwill F (2009) Tumour necrosis factor and cancer. Nat Rev Cancer 9(5):361

    Article  CAS  Google Scholar 

  5. Strieter RM, Kunkel SL, Bone RC (1993) Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med 21(10 Suppl):S447-463

    Article  CAS  Google Scholar 

  6. Ardizzoia A, Lissoni P, Brivio F, Tisi E, Perego M, Grassi M, Pittalis S, Crispino S, Barni S, Tancini G (1992) Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J Biol Regul Homeostat Agents 6(3):103–107

    CAS  Google Scholar 

  7. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci 94(7):3195–3199

    Article  CAS  Google Scholar 

  8. Raabe T, Bukrinsky M, Currie RA (1998) Relative contribution of transcription and translation to the induction of tumor necrosis factor-α by lipopolysaccharide. J Biol Chem 273(2):974–980

    Article  CAS  Google Scholar 

  9. Kroeger KM, Carville KS, Abraham LJ (1997) The− 308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 34(5):391–399

    Article  CAS  Google Scholar 

  10. Calhoun ES, McGovern RM, Janney CA, Cerhan JR, Iturria SJ, Smith DI, Gostout BS, Persing DH (2002) Host genetic polymorphism analysis in cervical cancer. Clin Chem 48(8):1218–1224

    Article  CAS  Google Scholar 

  11. Govan VA, Constant D, Hoffman M, Williamson A-L (2006) The allelic distribution of-308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women. BMC Cancer 6(1):24

    Article  Google Scholar 

  12. Babapour N, Mehramiz M, Rastgar Moghadam A, Behboodi N, Yousefi Z, Maftouh M, Talebian S, Khazaei M, Jafarian A, Sharifi-Sistani N, Avan A, Hasanzadeh M (2019) Association of TNF-308 G>A polymorphism located in tumor necrosis factor a with the risk of developing cervical cancer and results of pap smear. J Cell Biochem 120(4):5444–5448

    Article  CAS  Google Scholar 

  13. Oladi M, Nohtani M, Avan A, Mirhafez SR, Tajbakhsh A, Ghasemi F, Asadi A, Elahdadi Salmani M, Mohammadi A, Hoseinzadeh L (2015) Impact of the C1431T polymorphism of the peroxisome proliferator activated receptor-gamma (PPAR-γ) gene on fasted serum lipid levels in patients with coronary artery disease. Ann Nutr Metab 66(2–3):149–154

    Article  CAS  Google Scholar 

  14. Mehramiz M, Ghasemi F, Esmaily H, Tayefi M, Hassanian SM, Sadeghzade M, Sadabadi F, Moohebati M, Azarpazhooh MR, Parizadeh SM et al (2016) Interaction between a variant of CDKN2A/B-gene with lifestyle factors in determining dyslipidemia and estimated cardiovascular risk: a step toward personalized nutrition. Clin Nutr 37:254

    Article  Google Scholar 

  15. Zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2(5):342

    Article  CAS  Google Scholar 

  16. Hajeer AH, Hutchinson IV (2001) Influence of TNFα gene polymorphisms on TNFα production and disease. Hum Immunol 62(11):1191–1199

    Article  CAS  Google Scholar 

  17. Duarte I, Santos A, Sousa H, Catarino R, Pinto D, Matos A, Pereira D, Moutinho J, Canedo P, Machado JC (2005) G-308A TNF-α polymorphism is associated with an increased risk of invasive cervical cancer. Biochem Biophys Res Commun 334(2):588–592

    Article  CAS  Google Scholar 

  18. Jang WH, Yang Y-I, Yea SS, Lee YJ, Chun JH, Kim H-I, Kim MS, Paik K-H (2001) The-238 tumor necrosis factor-α promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 166(1):41–46

    Article  CAS  Google Scholar 

  19. Liu L, Yang X, Chen X, Kan T, Shen Y, Chen Z, Hu Z (2012) Association between TNF-α polymorphisms and cervical cancer risk: a meta-analysis. Mol Biol Rep 39(3):2683–2688

    Article  CAS  Google Scholar 

  20. Kirkpatrick A, Bidwell J, Van den Brule A, Meijer C, Pawade J, Glew S (2004) TNFα polymorphism frequencies in HPV-associated cervical dysplasia. Gynecol Oncol 92(2):675–679

    Article  CAS  Google Scholar 

  21. Stanczuk G, Sibanda E, Tswana S, Bergstrom S (2003) Polymorphism at the the− 308-promoter position of the tumor necrosis factor-alpha (TNF-α) gene and cervical cancer. Int J Gynecol Cancer 13(2):148–153

    CAS  PubMed  Google Scholar 

  22. Wang N, Yin D, Zhang S, Wei H, Wang S, Zhang Y, Lu Y, Dai S, Li W, Zhang Q (2012) TNF-αlpha rs1800629 polymorphism is not associated with HPV infection or cervical cancer in the Chinese population. PLoS ONE 7(9):e45246

    Article  CAS  Google Scholar 

Download references

Funding

This study was supported by a grant from Mashhad University of Medical Sciences.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Amir Avan or Malihe Hasanzadeh.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Behboodi, N., Farazestanian, M., Rastgar-Moghadam, A. et al. Association of a variant in the tumor necrosis factor alpha gene with risk of cervical cancer. Mol Biol Rep 48, 1433–1437 (2021). https://doi.org/10.1007/s11033-021-06185-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-021-06185-4

Keywords

Navigation